Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 78.46B P/E 50.78 EPS this Y 7.40% Ern Qtrly Grth 19.70%
Income 1.46B Forward P/E 20.09 EPS next Y 9.20% 50D Avg Chg 7.00%
Sales 19.83B PEG 2.13 EPS past 5Y 2.03% 200D Avg Chg 11.00%
Dividend 1.00% Price/Book 3.05 EPS next 5Y 8.65% 52W High Chg -4.00%
Recommedations 1.80 Quick Ratio 1.20 Shares Outstanding 289.04M 52W Low Chg 28.00%
Insider Own 0.28% ROA 3.25% Shares Float 288.42M Beta 0.45
Inst Own 90.03% ROE 5.63% Shares Shorted/Prior 2.73M/1.48M Price 276.24
Gross Margin 44.90% Profit Margin 7.13% Avg. Volume 1,216,300 Target Price 277.87
Oper. Margin 15.13% Earnings Date Nov 7 Volume 1,396,333 Change -0.83%
About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Becton, Dickinson and Company News
11/22/24 Becton Dickinson (NYSE:BDX) investors are sitting on a loss of 4.7% if they invested five years ago
11/20/24 First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities
11/19/24 BD to Present at the 7th Annual Evercore ISI HealthCONx Conference
11/18/24 Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
11/15/24 Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
11/14/24 Are Investors Undervaluing Becton, Dickinson and Company (NYSE:BDX) By 30%?
11/12/24 First Eagle Investment Bolsters Stake in Becton Dickinson & Co in Q3 2024
11/11/24 Are Investors Undervaluing Becton, Dickinson and Company (BDX) Right Now?
11/10/24 Becton, Dickinson and Company's (NYSE:BDX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
11/08/24 Becton Dickinson & Co (BDX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
11/07/24 Q4 2024 Becton Dickinson and Co Earnings Call
11/07/24 Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth
11/07/24 Looking for a Growth Stock? 3 Reasons Why Becton Dickinson (BDX) is a Solid Choice
11/07/24 BDX or MMSI: Which Is the Better Value Stock Right Now?
11/07/24 BDX Stock Gains Following Q4 Earnings Beat and Higher Margins
11/07/24 Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
11/07/24 Becton Dickinson (BDX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
11/07/24 Becton Dickinson Gives Upbeat Fiscal 2025 Guidance After Fourth-Quarter Beat
11/07/24 Becton Dickinson (BDX) Q4 Earnings and Revenues Surpass Estimates
11/07/24 Becton Dickinson: Fiscal Q4 Earnings Snapshot
BDX Chatroom

User Image YouOnlyLiveTwice Posted - 10 hours ago

$BDX Best hope for these stocks in this space is Consolidation or M&A โ€ฆ.they have done nothing for 5 years and that could continue unless thereโ€™s a shock to the industry

User Image BenReynoldsIV Posted - 14 hours ago

๐™’๐™๐™š๐™ฉ๐™๐™š๐™ง ๐™ฌ๐™šโ€™๐™ง๐™š ๐™ฉ๐™–๐™ก๐™ ๐™ž๐™ฃ๐™œ ๐™–๐™—๐™ค๐™ช๐™ฉ ๐™จ๐™ค๐™˜๐™ ๐™จ ๐™ค๐™ง ๐™จ๐™ฉ๐™ค๐™˜๐™ ๐™จ, ๐™„ ๐™ก๐™ž๐™ ๐™š ๐™—๐™ช๐™ฎ๐™ž๐™ฃ๐™œ ๐™ฆ๐™ช๐™–๐™ก๐™ž๐™ฉ๐™ฎ ๐™ข๐™š๐™ง๐™˜๐™๐™–๐™ฃ๐™™๐™ž๐™จ๐™š ๐™ฌ๐™๐™š๐™ฃ ๐™ž๐™ฉ ๐™ž๐™จ ๐™ข๐™–๐™ง๐™ ๐™š๐™™ ๐™™๐™ค๐™ฌ๐™ฃ.โ€ - Warren Buffett Looking for high quality merchandise in the stock market? Consider the Dividend Kings - an elite group of all 54 stocks with 50+ years of consecutive dividend increases. Now for the "marked down" part of Buffett's quote... The 5 cheapest Dividend Kings based on their 52-week lows are: $BDX 2.9% off 52-week low $TGT 2.9% off 52-week low $PEP 3.4% off 52-week low $PPG 3.6% off 52-week low $FUL 3.6% off 52-week low Bonus: Click the following link to download your free spreadsheet of all 54 Dividend Kings now - https://www.suredividend.com/dividend-kings-lp2-st/

User Image YouOnlyLiveTwice Posted - 2 days ago

$BDX $ICUI Both of which posted great numbers and raised guidanceโ€ฆ

User Image YouOnlyLiveTwice Posted - 2 days ago

$BDX Approaching a 5 year low

User Image zztopps Posted - 2 days ago

$BDX Continued disappointment . Where's an activist when you need one? Years of pitiful underperformance.

User Image 11thestate Posted - 3 days ago

$BDX agreed to settle for $85M to resolve claims that it misled investors about the functionality and safety of its Alaris infusion pumps. Even if you missed the deadline, if you bought between November 05, 2019, and February 05, 2020, you can still file a late claim here: https://11thestate.com/cases/bdx-shareholder-settlement

User Image YouOnlyLiveTwice Posted - 1 week ago

$BDX All medical device and anything related to health care hasnโ€™t gotten hit for the last 5 days many of which have beat and raised โ€ฆ Meanwhile Coin-base which has 0 earnings is up 75% lol

User Image swingingtech Posted - 1 week ago

$BDX $SJW $RGLD $NUE $SYY https://wallstreetwaves.com/5-dividend-growth-stocks-with-upside-to-analyst-targets/

User Image Monkey_Banana_Genius Posted - 1 week ago

$BDX ๐Ÿ‘€

User Image Villidj_Idjit Posted - 1 week ago

$BDX https://summamoney.com/investing/the-spotlight/647710/

User Image DividendPower Posted - 2 weeks ago

Recent Dividend Increases - Updated 11/08/24 https://www.dividendpower.org/dividend-increases/ $TNC $ROP $LANC $ATO $BDX

User Image Monkey_Banana_Genius Posted - 2 weeks ago

$BDX ๐Ÿ‘€

User Image EarningsCallSamurAI Posted - 2 weeks ago

$BDX Financial Performance Highlights From Last Earnings Call The company delivered impressive results in Q4 2024: * Revenue grew 7.4% with organic growth of 6.2% * Adjusted diluted EPS increased 11.4% to $3.81 * Operating margin expanded by 120 basis points year-over-year to 26.6% * Full-year free cash flow reached $3.1 billion, up 47% These results reflect BDโ€™s ability to execute its strategic initiatives while managing market pressures effectively. Check our latest blog post! https://blog.earningscallsamurai.com/https-earningscallsamurai-com-bd-q4-2024-earnings-analysis/

User Image Joslvtr99 Posted - 2 weeks ago

$BDX this is a easy buy

User Image theviolator Posted - 2 weeks ago

$BDX does thing ever move. Every time it comes on my screen itโ€™s 230 lol

User Image EarningsCentral Posted - 2 weeks ago

$BDX Earnings Recap for Q4 2024: Revenue & EPS Beat, Margins Grow https://youtu.be/9lyjoEm4NXo

User Image Monkey_Banana_Genius Posted - 2 weeks ago

$BDX added under $231

User Image zztopps Posted - 2 weeks ago

$BDX So disappointing. This thing just can't get out of its own way.

User Image theflynews Posted - 2 weeks ago

Morning Movers: Under Armour and Lyft soar following earnings - $BDX - https://thefly.com/permalinks/entry.php/BDXid4016399

User Image Tokenist Posted - 2 weeks ago

๐ŸšจEARNINGS ALERT๐Ÿšจ Notable earnings released for today: Duke Energy Corporation $DUK: $1.62 EPS vs $1.74 est. / $8.15B Revenue vs $8.06B est. Air Products and Chemicals Inc $APD: $3.56 EPS vs $3.48 est. / $93.19B Revenue vs $3.22B est. Becton Dickinson and Company $BDX: $3.81 EPS vs $3.77 est. / $5.4B Revenue vs $25.37B est. EPAM Systems $EPAM: $3.12 EPS vs $2.7 est. / $1.17B Revenue vs $1.15B est.

User Image DonCorleone77 Posted - 2 weeks ago

$BDX Becton Dickinson sees FY25 adjusted EPS $14.25-$14.60, consensus $14.34 Sees FY25 revenue up 8.9%-9.4%. The company said, "The company provided the following guidance with respect to fiscal 2025. GAAP revenue growth of 8.9% to 9.4% and currency-neutral adjusted revenue growth of 8.8% to 9.3% include the newly acquired APM business. The company's organic revenue growth guidance of 4.0% to 4.5% includes absorbing an impact about 125 basis points from an expected decline in revenues in China and Bioscience and Pharma market dynamics."

User Image 11thestate Posted - 2 weeks ago

$BDX agreed to settle for $85M to resolve claims that it misled investors about the functionality and safety of its Alaris infusion pumps. Even if you missed the deadline, if you bought between November 05, 2019, and February 05, 2020, you can still file a late claim here: https://11thestate.com/cases/bdx-shareholder-settlement

User Image DivergenceSeeker Posted - 2 weeks ago

$BDX Excellent long term play! Love it as a stock to accumulate.

User Image Stocksrunner Posted - 10/30/24

๐ŸŒŸ Curious about the buzz in the market today? Let's just say a few stocks are catching some serious attention. Keep an eye on $BDX $CHE $CL $DAR and $LEVIโ€”they're the ones everyone's whispering about. Want to know more? You'll just have to stick around. ๐Ÿ˜‰ https://stocksrunner.com/posts/1317

User Image 11thestate Posted - 10/29/24

$BDX agreed to settle for $85M to resolve claims that it misled investors about the functionality and safety of its Alaris infusion pumps. Even if you missed the deadline, if you bought between November 05, 2019, and February 05, 2020, you can still file a late claim here: https://11thestate.com/cases/bdx-shareholder-settlement

User Image swingingtech Posted - 10/29/24

$BDX https://wallstreetwaves.com/becton-dickinson-and-company-earnings-forecast-insights-ahead-of-the-report/

User Image Himel92 Posted - 10/24/24

The Last month Performance for $BDX Opening Price: $235.74 Closing Price: $240.52 Highest Price: $244.50 Lowest Price: $232.87 Percentage Change: 2.03% Data provider: AITX

User Image JackDarwin Posted - 4 weeks ago

$BDX Bullish Engulfing Formed.

User Image WeeklyTrader Posted - 4 weeks ago

Higher highs for $BDX! RSI: 52.59% 50-day MA: $237.1 200-day MA: $236.51

User Image 11thestate Posted - 1 month ago

$BDX agreed to settle for $85M to resolve claims that it misled investors about the functionality and safety of its Alaris infusion pumps. Even if you missed the deadline, if you bought between November 05, 2019, and February 05, 2020, you can still file a late claim here: https://11thestate.com/cases/bdx-shareholder-settlement

Analyst Ratings
Evercore ISI Group Outperform Oct 1, 24
Citigroup Buy Oct 1, 24
Raymond James Outperform Aug 2, 24
Stifel Buy Jul 26, 24
Citigroup Neutral Jul 10, 24
Evercore ISI Group Outperform Jul 2, 24
Goldman Sachs Buy May 30, 24
Barclays Overweight May 6, 24
Barclays Overweight Feb 5, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Byrd Richard EVP & President Inte.. EVP & President Interventional Nov 28 Sell 238.47 2,156 514,141 4,120 11/29/23
Byrd Richard EVP & President Inte.. EVP & President Interventional Sep 05 Sell 274.48 459 125,986 3,444 09/06/23
Fraser Claire Director Director Aug 28 Sell 281.66 848 238,848 21,608 08/30/23
Garrison Michael David EVP & President Medi.. EVP & President Medical Aug 08 Sell 277.13 1,300 360,269 5,157 08/09/23
Goette Roland EVP and President, E.. EVP and President, EMEA Nov 16 Option 74.94 4,617 345,998 14,896 11/18/22
Hickey David EVP & President, Lif.. EVP & President, Life Sciences Aug 15 Sell 265.00 475 125,875 3,331 08/17/22
Polen Thomas E Jr Chairman, CEO and Pr.. Chairman, CEO and President Aug 15 Option 167.91 15,000 2,518,650 43,878 08/17/22
Polen Thomas E Jr Chairman, CEO and Pr.. Chairman, CEO and President Aug 15 Sell 265.13 9,500 2,518,735 28,878 08/17/22
Spoerel Thomas J VP Controller & Chie.. VP Controller & Chief Acct Off Jun 07 Sell 260 443 115,180 1,058 06/09/22
Spoerel Thomas J VP Controller & Chie.. VP Controller & Chief Acct Off Jun 07 Option 147.68 1,026 151,520 2,070 06/09/22
Hickey David EVP & President, Lif.. EVP & President, Life Sciences May 06 Sell 256 475 121,600 3,806 05/10/22
Larson Betty D EVP HR & CHRO EVP HR & CHRO Feb 25 Option 193.09 46,658 9,009,193 9,556 02/28/22
Larson Betty D EVP HR & CHRO EVP HR & CHRO Feb 25 Sell 271.9 14,374 3,908,291 5,872 02/28/22
Fraser Claire Director Director Feb 08 Sell 271.70 841 228,500 21,556 02/10/22
Conroy Alexandre EVP of Integrated Su.. EVP of Integrated Supply Chain Feb 03 Option 134.73 12,787 1,722,793 34,047 02/07/22
Conroy Alexandre EVP of Integrated Su.. EVP of Integrated Supply Chain Feb 03 Sell 270.16 6,410 1,731,726 21,260 02/07/22
Lim James C Executive Vice Presi.. Executive Vice President Sep 07 Sell 257.44 6,956 1,790,753 19,768 09/07/21
Lim James C Executive Vice Presi.. Executive Vice President Sep 07 Option 134.73 14,584 1,964,902 34,352 09/07/21